- Home
- KOSS vs VSTM Comparison
KOSS vs VSTM Comparison
Compare KOSS & VSTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KOSS
- VSTM
- Stock Information
- Founded
- KOSS 1953
- VSTM 2010
- Country
- KOSS United States
- VSTM United States
- Employees
- KOSS N/A
- VSTM N/A
- Industry
- KOSS Consumer Electronics/Appliances
- VSTM Biotechnology: Pharmaceutical Preparations
- Sector
- KOSS Consumer Staples
- VSTM Health Care
- Exchange
- KOSS Nasdaq
- VSTM Nasdaq
- Market Cap
- KOSS 59.3M
- VSTM 425.9M
- IPO Year
- KOSS N/A
- VSTM 2012
- Fundamental
- Price
- KOSS $5.25
- VSTM $4.79
- Analyst Decision
- KOSS
- VSTM Strong Buy
- Analyst Count
- KOSS 0
- VSTM 9
- Target Price
- KOSS N/A
- VSTM $12.63
- AVG Volume (30 Days)
- KOSS 89.1K
- VSTM 2.5M
- Earning Date
- KOSS 08-28-2025
- VSTM 08-07-2025
- Dividend Yield
- KOSS N/A
- VSTM N/A
- EPS Growth
- KOSS N/A
- VSTM N/A
- EPS
- KOSS N/A
- VSTM N/A
- Revenue
- KOSS $12,433,361.00
- VSTM $10,000,000.00
- Revenue This Year
- KOSS N/A
- VSTM $129.06
- Revenue Next Year
- KOSS N/A
- VSTM $306.32
- P/E Ratio
- KOSS N/A
- VSTM N/A
- Revenue Growth
- KOSS N/A
- VSTM N/A
- 52 Week Low
- KOSS $4.00
- VSTM $2.10
- 52 Week High
- KOSS $12.89
- VSTM $9.10
- Technical
- Relative Strength Index (RSI)
- KOSS 50.81
- VSTM 38.77
- Support Level
- KOSS $5.12
- VSTM $4.01
- Resistance Level
- KOSS $5.37
- VSTM $5.06
- Average True Range (ATR)
- KOSS 0.27
- VSTM 0.35
- MACD
- KOSS 0.03
- VSTM 0.06
- Stochastic Oscillator
- KOSS 51.46
- VSTM 41.42
About KOSS Koss Corporation
Koss Corp is engaged in the design, manufacture, and sale of stereo headphones and related accessory products. It operates in the audio/video industry segment of the home entertainment industry. The company markets a line of headphones, wireless Bluetooth headphones, wireless Bluetooth speakers, computer headsets, telecommunications headsets, and active noise-canceling headphones. The majority of the firm's revenue is derived from sales of stereo headphones.
About VSTM Verastem Inc.
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.